0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Iron Chelation Drug Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-9L9352
Home | Market Reports | Health | Nutrition | Vitamins & Supplements
Global Iron Chelation Drug Market Insights and Forecast to 2028

Global Iron Chelation Drug Market Insights and Forecast to 2028

Code: QYRE-Auto-9L9352
Report
January 2022
92 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
In a healthy body, when the stores of iron are sufficient, the intestines reduce the absorption of this mineral from food and drink to prevent its levels from rising too high.
People with iron overload disorders absorb more iron than usual from food or supplements. The body cannot excrete the extra iron fast enough, so it continues to build up. The body stores it in organ tissue, mainly in the liver, as well as the heart and the pancreas.
There are several types of iron overload disorder. Hereditary hemochromatosis is a primary condition that has a genetic component. People can also have secondary hemochromatosis, which develops as a result of another disease or condition.
The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is >1000 μg/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin.
Market Analysis and Insights: Global Iron Chelation Drug Market

Due to the COVID-19 pandemic, the global Iron Chelation Drug market size is estimated to be worth US$ 661.5 million in 2022 and is forecast to a readjusted size of US$ 430.7 million by 2028 with a CAGR of -6.9% during the review period.

Fully considering the economic change by this health crisis, Deferasirox accounting for % of the Iron Chelation Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Transfusional Iron Overload segment is altered to an % CAGR throughout this forecast period.
Global Iron Chelation Drug key players include Novartis, Chiesi Group, Sun Pharma, Cipla, Natco Pharma, etc. Global top five manufacturers hold a Revenue Market Share over 35%. Europe accounts for the most Sales Market Share, which have a share over 40%, followed by North America. In terms of product, Deferasirox is the largest segment, with a Revenue Market Share over 90%. And in terms of application, the largest Application is Transfusional Iron Overload, followed by NTDT Caused Iron Overload.
Global Iron Chelation Drug Scope and Segment
Iron Chelation Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Iron Chelation Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Deferasirox
Deferoxamine
Deferiprone

Segment by Application

Transfusional Iron Overload
NTDT Caused Iron Overload

BY COMPANY

Novartis
Chiesi Group
Sun Pharma
Cipla
Natco Pharma
Taro Pharm
Gland Pharma

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Iron Chelation Drug Product Introduction
1.2 Market by Type
1.2.1 Global Iron Chelation Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Deferasirox
1.2.3 Deferoxamine
1.2.4 Deferiprone
1.3 Market by Application
1.3.1 Global Iron Chelation Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Transfusional Iron Overload
1.3.3 NTDT Caused Iron Overload
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Iron Chelation Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Iron Chelation Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Iron Chelation Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Iron Chelation Drug Sales by Region
2.4.1 Global Iron Chelation Drug Sales by Region (2017-2022)
2.4.2 Global Sales Iron Chelation Drug by Region (2023-2028)
2.5 Global Iron Chelation Drug Revenue by Region
2.5.1 Global Iron Chelation Drug Revenue by Region (2017-2022)
2.5.2 Global Iron Chelation Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Iron Chelation Drug Sales by Manufacturers
3.1.1 Global Top Iron Chelation Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Iron Chelation Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Iron Chelation Drug in 2021
3.2 Global Iron Chelation Drug Revenue by Manufacturers
3.2.1 Global Iron Chelation Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Iron Chelation Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Iron Chelation Drug Revenue in 2021
3.3 Global Iron Chelation Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Iron Chelation Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Iron Chelation Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Iron Chelation Drug Sales by Type
4.1.1 Global Iron Chelation Drug Historical Sales by Type (2017-2022)
4.1.2 Global Iron Chelation Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Iron Chelation Drug Sales Market Share by Type (2017-2028)
4.2 Global Iron Chelation Drug Revenue by Type
4.2.1 Global Iron Chelation Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Iron Chelation Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Iron Chelation Drug Revenue Market Share by Type (2017-2028)
4.3 Global Iron Chelation Drug Price by Type
4.3.1 Global Iron Chelation Drug Price by Type (2017-2022)
4.3.2 Global Iron Chelation Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Iron Chelation Drug Sales by Application
5.1.1 Global Iron Chelation Drug Historical Sales by Application (2017-2022)
5.1.2 Global Iron Chelation Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Iron Chelation Drug Sales Market Share by Application (2017-2028)
5.2 Global Iron Chelation Drug Revenue by Application
5.2.1 Global Iron Chelation Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Iron Chelation Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Iron Chelation Drug Revenue Market Share by Application (2017-2028)
5.3 Global Iron Chelation Drug Price by Application
5.3.1 Global Iron Chelation Drug Price by Application (2017-2022)
5.3.2 Global Iron Chelation Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Iron Chelation Drug Market Size by Type
6.1.1 North America Iron Chelation Drug Sales by Type (2017-2028)
6.1.2 North America Iron Chelation Drug Revenue by Type (2017-2028)
6.2 North America Iron Chelation Drug Market Size by Application
6.2.1 North America Iron Chelation Drug Sales by Application (2017-2028)
6.2.2 North America Iron Chelation Drug Revenue by Application (2017-2028)
6.3 North America Iron Chelation Drug Market Size by Country
6.3.1 North America Iron Chelation Drug Sales by Country (2017-2028)
6.3.2 North America Iron Chelation Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Iron Chelation Drug Market Size by Type
7.1.1 Europe Iron Chelation Drug Sales by Type (2017-2028)
7.1.2 Europe Iron Chelation Drug Revenue by Type (2017-2028)
7.2 Europe Iron Chelation Drug Market Size by Application
7.2.1 Europe Iron Chelation Drug Sales by Application (2017-2028)
7.2.2 Europe Iron Chelation Drug Revenue by Application (2017-2028)
7.3 Europe Iron Chelation Drug Market Size by Country
7.3.1 Europe Iron Chelation Drug Sales by Country (2017-2028)
7.3.2 Europe Iron Chelation Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Iron Chelation Drug Market Size by Type
8.1.1 Asia Pacific Iron Chelation Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Iron Chelation Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Iron Chelation Drug Market Size by Application
8.2.1 Asia Pacific Iron Chelation Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Iron Chelation Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Iron Chelation Drug Market Size by Region
8.3.1 Asia Pacific Iron Chelation Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Iron Chelation Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Iron Chelation Drug Market Size by Type
9.1.1 Latin America Iron Chelation Drug Sales by Type (2017-2028)
9.1.2 Latin America Iron Chelation Drug Revenue by Type (2017-2028)
9.2 Latin America Iron Chelation Drug Market Size by Application
9.2.1 Latin America Iron Chelation Drug Sales by Application (2017-2028)
9.2.2 Latin America Iron Chelation Drug Revenue by Application (2017-2028)
9.3 Latin America Iron Chelation Drug Market Size by Country
9.3.1 Latin America Iron Chelation Drug Sales by Country (2017-2028)
9.3.2 Latin America Iron Chelation Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Iron Chelation Drug Market Size by Type
10.1.1 Middle East and Africa Iron Chelation Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Iron Chelation Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Iron Chelation Drug Market Size by Application
10.2.1 Middle East and Africa Iron Chelation Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Iron Chelation Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Iron Chelation Drug Market Size by Country
10.3.1 Middle East and Africa Iron Chelation Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Iron Chelation Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Iron Chelation Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Iron Chelation Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Chiesi Group
11.2.1 Chiesi Group Corporation Information
11.2.2 Chiesi Group Overview
11.2.3 Chiesi Group Iron Chelation Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Chiesi Group Iron Chelation Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Chiesi Group Recent Developments
11.3 Sun Pharma
11.3.1 Sun Pharma Corporation Information
11.3.2 Sun Pharma Overview
11.3.3 Sun Pharma Iron Chelation Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sun Pharma Iron Chelation Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sun Pharma Recent Developments
11.4 Cipla
11.4.1 Cipla Corporation Information
11.4.2 Cipla Overview
11.4.3 Cipla Iron Chelation Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Cipla Iron Chelation Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cipla Recent Developments
11.5 Natco Pharma
11.5.1 Natco Pharma Corporation Information
11.5.2 Natco Pharma Overview
11.5.3 Natco Pharma Iron Chelation Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Natco Pharma Iron Chelation Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Natco Pharma Recent Developments
11.6 Taro Pharm
11.6.1 Taro Pharm Corporation Information
11.6.2 Taro Pharm Overview
11.6.3 Taro Pharm Iron Chelation Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Taro Pharm Iron Chelation Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Taro Pharm Recent Developments
11.7 Gland Pharma
11.7.1 Gland Pharma Corporation Information
11.7.2 Gland Pharma Overview
11.7.3 Gland Pharma Iron Chelation Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Gland Pharma Iron Chelation Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Gland Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Iron Chelation Drug Industry Chain Analysis
12.2 Iron Chelation Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Iron Chelation Drug Production Mode & Process
12.4 Iron Chelation Drug Sales and Marketing
12.4.1 Iron Chelation Drug Sales Channels
12.4.2 Iron Chelation Drug Distributors
12.5 Iron Chelation Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Iron Chelation Drug Industry Trends
13.2 Iron Chelation Drug Market Drivers
13.3 Iron Chelation Drug Market Challenges
13.4 Iron Chelation Drug Market Restraints
14 Key Findings in The Global Iron Chelation Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Iron Chelation Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Deferasirox
    Table 3. Major Manufacturers of Deferoxamine
    Table 4. Major Manufacturers of Deferiprone
    Table 5. Global Iron Chelation Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Iron Chelation Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Iron Chelation Drug Sales by Region (2017-2022) & (K Units)
    Table 8. Global Iron Chelation Drug Sales Market Share by Region (2017-2022)
    Table 9. Global Iron Chelation Drug Sales by Region (2023-2028) & (K Units)
    Table 10. Global Iron Chelation Drug Sales Market Share by Region (2023-2028)
    Table 11. Global Iron Chelation Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Iron Chelation Drug Revenue Market Share by Region (2017-2022)
    Table 13. Global Iron Chelation Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Iron Chelation Drug Revenue Market Share by Region (2023-2028)
    Table 15. Global Iron Chelation Drug Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Iron Chelation Drug Sales Share by Manufacturers (2017-2022)
    Table 17. Global Iron Chelation Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Iron Chelation Drug Revenue Share by Manufacturers (2017-2022)
    Table 19. Iron Chelation Drug Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 20. Global Iron Chelation Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Iron Chelation Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iron Chelation Drug as of 2021)
    Table 22. Iron Chelation Drug Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Iron Chelation Drug Product Offered
    Table 24. Date of Manufacturers Enter into Iron Chelation Drug Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Iron Chelation Drug Sales by Type (2017-2022) & (K Units)
    Table 27. Global Iron Chelation Drug Sales by Type (2023-2028) & (K Units)
    Table 28. Global Iron Chelation Drug Sales Share by Type (2017-2022)
    Table 29. Global Iron Chelation Drug Sales Share by Type (2023-2028)
    Table 30. Global Iron Chelation Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Iron Chelation Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Iron Chelation Drug Revenue Share by Type (2017-2022)
    Table 33. Global Iron Chelation Drug Revenue Share by Type (2023-2028)
    Table 34. Iron Chelation Drug Price by Type (2017-2022) & (US$/Unit)
    Table 35. Global Iron Chelation Drug Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 36. Global Iron Chelation Drug Sales by Application (2017-2022) & (K Units)
    Table 37. Global Iron Chelation Drug Sales by Application (2023-2028) & (K Units)
    Table 38. Global Iron Chelation Drug Sales Share by Application (2017-2022)
    Table 39. Global Iron Chelation Drug Sales Share by Application (2023-2028)
    Table 40. Global Iron Chelation Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Iron Chelation Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Iron Chelation Drug Revenue Share by Application (2017-2022)
    Table 43. Global Iron Chelation Drug Revenue Share by Application (2023-2028)
    Table 44. Iron Chelation Drug Price by Application (2017-2022) & (US$/Unit)
    Table 45. Global Iron Chelation Drug Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 46. North America Iron Chelation Drug Sales by Type (2017-2022) & (K Units)
    Table 47. North America Iron Chelation Drug Sales by Type (2023-2028) & (K Units)
    Table 48. North America Iron Chelation Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Iron Chelation Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Iron Chelation Drug Sales by Application (2017-2022) & (K Units)
    Table 51. North America Iron Chelation Drug Sales by Application (2023-2028) & (K Units)
    Table 52. North America Iron Chelation Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Iron Chelation Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Iron Chelation Drug Sales by Country (2017-2022) & (K Units)
    Table 55. North America Iron Chelation Drug Sales by Country (2023-2028) & (K Units)
    Table 56. North America Iron Chelation Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Iron Chelation Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Iron Chelation Drug Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Iron Chelation Drug Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Iron Chelation Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Iron Chelation Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Iron Chelation Drug Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Iron Chelation Drug Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Iron Chelation Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Iron Chelation Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Iron Chelation Drug Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Iron Chelation Drug Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Iron Chelation Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Iron Chelation Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Iron Chelation Drug Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Iron Chelation Drug Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Iron Chelation Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Iron Chelation Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Iron Chelation Drug Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Iron Chelation Drug Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Iron Chelation Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Iron Chelation Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Iron Chelation Drug Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Iron Chelation Drug Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Iron Chelation Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Iron Chelation Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Iron Chelation Drug Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Iron Chelation Drug Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Iron Chelation Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Iron Chelation Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Iron Chelation Drug Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Iron Chelation Drug Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Iron Chelation Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Iron Chelation Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Iron Chelation Drug Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Iron Chelation Drug Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Iron Chelation Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Iron Chelation Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Iron Chelation Drug Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Iron Chelation Drug Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Iron Chelation Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Iron Chelation Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Iron Chelation Drug Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Iron Chelation Drug Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Iron Chelation Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Iron Chelation Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Iron Chelation Drug Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Iron Chelation Drug Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Iron Chelation Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Iron Chelation Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Novartis Corporation Information
    Table 107. Novartis Description and Major Businesses
    Table 108. Novartis Iron Chelation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 109. Novartis Iron Chelation Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Novartis Recent Developments
    Table 111. Chiesi Group Corporation Information
    Table 112. Chiesi Group Description and Major Businesses
    Table 113. Chiesi Group Iron Chelation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 114. Chiesi Group Iron Chelation Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Chiesi Group Recent Developments
    Table 116. Sun Pharma Corporation Information
    Table 117. Sun Pharma Description and Major Businesses
    Table 118. Sun Pharma Iron Chelation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 119. Sun Pharma Iron Chelation Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Sun Pharma Recent Developments
    Table 121. Cipla Corporation Information
    Table 122. Cipla Description and Major Businesses
    Table 123. Cipla Iron Chelation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 124. Cipla Iron Chelation Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Cipla Recent Developments
    Table 126. Natco Pharma Corporation Information
    Table 127. Natco Pharma Description and Major Businesses
    Table 128. Natco Pharma Iron Chelation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 129. Natco Pharma Iron Chelation Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Natco Pharma Recent Developments
    Table 131. Taro Pharm Corporation Information
    Table 132. Taro Pharm Description and Major Businesses
    Table 133. Taro Pharm Iron Chelation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 134. Taro Pharm Iron Chelation Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Taro Pharm Recent Developments
    Table 136. Gland Pharma Corporation Information
    Table 137. Gland Pharma Description and Major Businesses
    Table 138. Gland Pharma Iron Chelation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 139. Gland Pharma Iron Chelation Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Gland Pharma Recent Developments
    Table 141. Key Raw Materials Lists
    Table 142. Raw Materials Key Suppliers Lists
    Table 143. Iron Chelation Drug Distributors List
    Table 144. Iron Chelation Drug Customers List
    Table 145. Iron Chelation Drug Market Trends
    Table 146. Iron Chelation Drug Market Drivers
    Table 147. Iron Chelation Drug Market Challenges
    Table 148. Iron Chelation Drug Market Restraints
    Table 149. Research Programs/Design for This Report
    Table 150. Key Data Information from Secondary Sources
    Table 151. Key Data Information from Primary Sources
List of Figures
    Figure 1. Iron Chelation Drug Product Picture
    Figure 3. Global Iron Chelation Drug Market Share by Type in 2021 & 2028
    Figure 3. Deferasirox Product Picture
    Figure 4. Deferoxamine Product Picture
    Figure 5. Deferiprone Product Picture
    Figure 6. Global Iron Chelation Drug Market Share by Application in 2021 & 2028
    Figure 7. Transfusional Iron Overload
    Figure 8. NTDT Caused Iron Overload
    Figure 9. Iron Chelation Drug Report Years Considered
    Figure 10. Global Iron Chelation Drug Sales 2017-2028 (K Units)
    Figure 11. Global Iron Chelation Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Iron Chelation Drug Revenue 2017-2028 (US$ Million)
    Figure 13. Global Iron Chelation Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Iron Chelation Drug Sales Market Share by Region (2017-2022)
    Figure 15. Global Iron Chelation Drug Sales Market Share by Region (2023-2028)
    Figure 16. North America Iron Chelation Drug Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Iron Chelation Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Iron Chelation Drug Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Iron Chelation Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Iron Chelation Drug Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Iron Chelation Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Iron Chelation Drug Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Iron Chelation Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Iron Chelation Drug Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Iron Chelation Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Iron Chelation Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Iron Chelation Drug in the World: Market Share by Iron Chelation Drug Revenue in 2021
    Figure 28. Global Iron Chelation Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Iron Chelation Drug Sales Market Share by Type (2017-2028)
    Figure 30. Global Iron Chelation Drug Revenue Market Share by Type (2017-2028)
    Figure 31. Global Iron Chelation Drug Sales Market Share by Application (2017-2028)
    Figure 32. Global Iron Chelation Drug Revenue Market Share by Application (2017-2028)
    Figure 33. North America Iron Chelation Drug Sales Market Share by Type (2017-2028)
    Figure 34. North America Iron Chelation Drug Revenue Market Share by Type (2017-2028)
    Figure 35. North America Iron Chelation Drug Sales Market Share by Application (2017-2028)
    Figure 36. North America Iron Chelation Drug Revenue Market Share by Application (2017-2028)
    Figure 37. North America Iron Chelation Drug Sales Share by Country (2017-2028)
    Figure 38. North America Iron Chelation Drug Revenue Share by Country (2017-2028)
    Figure 39. U.S. Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Iron Chelation Drug Sales Market Share by Type (2017-2028)
    Figure 42. Europe Iron Chelation Drug Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Iron Chelation Drug Sales Market Share by Application (2017-2028)
    Figure 44. Europe Iron Chelation Drug Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Iron Chelation Drug Sales Share by Country (2017-2028)
    Figure 46. Europe Iron Chelation Drug Revenue Share by Country (2017-2028)
    Figure 47. Germany Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 48. France Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Iron Chelation Drug Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Iron Chelation Drug Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Iron Chelation Drug Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Iron Chelation Drug Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Iron Chelation Drug Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Iron Chelation Drug Revenue Share by Region (2017-2028)
    Figure 58. China Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 61. India Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Iron Chelation Drug Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Iron Chelation Drug Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Iron Chelation Drug Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Iron Chelation Drug Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Iron Chelation Drug Sales Share by Country (2017-2028)
    Figure 73. Latin America Iron Chelation Drug Revenue Share by Country (2017-2028)
    Figure 74. Mexico Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Iron Chelation Drug Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Iron Chelation Drug Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Iron Chelation Drug Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Iron Chelation Drug Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Iron Chelation Drug Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Iron Chelation Drug Revenue Share by Country (2017-2028)
    Figure 83. Turkey Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Iron Chelation Drug Revenue (2017-2028) & (US$ Million)
    Figure 86. Iron Chelation Drug Value Chain
    Figure 87. Iron Chelation Drug Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global Holmium sulfate hydrate Market Insights Forecast to 2028
Global Holmium sulfate hydrate Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-24R7610
Wed May 18 00:00:00 UTC 2022

Add to Cart

Global Potassium molybdate Market Insights Forecast to 2028
Global Potassium molybdate Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-15A7898
Wed May 18 00:00:00 UTC 2022

Add to Cart

Global 2 Amino 3 1H Imidazol 4 Yl Propanoic Acid Market Insights and Forecast to 2028
Global 2-Amino-3-(1H-Imidazol-4-Yl)Propanoic Acid Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-36Y1952
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Calcium Levofolinate Market Insights and Forecast to 2028
Global Calcium Levofolinate Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-30M5663
Tue May 03 00:00:00 UTC 2022

Add to Cart